BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 26421298)

  • 1. Heterogeneity of Breast Cancer Associations with Common Genetic Variants in FGFR2 according to the Intrinsic Subtypes in Southern Han Chinese Women.
    Liang H; Yang X; Chen L; Li H; Zhu A; Sun M; Wang H; Li M
    Biomed Res Int; 2015; 2015():626948. PubMed ID: 26421298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study on genetic variants of Fibroblast growth factor receptor 2 (FGFR2) and the risk of breast cancer from North India.
    Siddiqui S; Chattopadhyay S; Akhtar MS; Najm MZ; Deo SV; Shukla NK; Husain SA
    PLoS One; 2014; 9(10):e110426. PubMed ID: 25333473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
    Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
    Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variants of FGFR2 and their associations with breast cancer risk: a HUGE systematic review and meta-analysis.
    Cui F; Wu D; Wang W; He X; Wang M
    Breast Cancer Res Treat; 2016 Jan; 155(2):313-35. PubMed ID: 26728143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of germline variation in CCNE1 and CDK2 with breast cancer risk, progression and survival among Chinese Han women.
    Han JY; Wang H; Xie YT; Li Y; Zheng LY; Ruan Y; Song AP; Tian XX; Fang WG
    PLoS One; 2012; 7(11):e49296. PubMed ID: 23185313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between fibroblast growth factor receptor-2 gene polymorphism and risk of breast cancer in Chinese populations: A HuGE review and meta-analysis.
    Yang YB; Zhao ZX; Huang W; Liu H; Tan YL; Wang WM
    J Cancer Res Ther; 2016; 12(2):543-9. PubMed ID: 27461607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
    Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
    Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of common genetic variants with breast cancer risk and clinicopathological characteristics in a Chinese population.
    Chan M; Ji SM; Liaw CS; Yap YS; Law HY; Yoon CS; Wong CY; Yong WS; Wong NS; Ng R; Ong KW; Madhukumar P; Oey CL; Tan PH; Li HH; Ang P; Ho GH; Lee AS
    Breast Cancer Res Treat; 2012 Nov; 136(1):209-20. PubMed ID: 22965832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms in second intron of the FGFR2 gene are associated with the risk of early-onset breast cancer in Chinese Han women.
    Fu F; Wang C; Huang M; Song C; Lin S; Huang H
    Tohoku J Exp Med; 2012 Mar; 226(3):221-9. PubMed ID: 22374580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype.
    Han W; Woo JH; Yu JH; Lee MJ; Moon HG; Kang D; Noh DY
    Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):793-8. PubMed ID: 21415360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
    Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
    Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The association of genetic variants in
    Yang Y; Fei M; Zhou X; Li Y; Jin D
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31113874
    [No Abstract]   [Full Text] [Related]  

  • 13. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
    Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
    PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
    Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
    Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of Genetic Variants at Nongenic Susceptibility Loci with Breast Cancer Risk and Heterogeneity by Tumor Subtype in Southern Han Chinese Women.
    Liang H; Li H; Yang X; Chen L; Zhu A; Sun M; Ye C; Li M
    Biomed Res Int; 2016; 2016():3065493. PubMed ID: 27022606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of CD40 gene polymorphisms with sporadic breast cancer in Chinese Han women of Northeast China.
    Shuang C; Dalin L; Weiguang Y; Zhenkun F; Fengyan X; Da P; Li D
    PLoS One; 2011; 6(8):e23762. PubMed ID: 21912605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
    Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
    Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
    Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC
    Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
    Wang H; Yang Z; Zhang H
    Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations.
    Raskin L; Pinchev M; Arad C; Lejbkowicz F; Tamir A; Rennert HS; Rennert G; Gruber SB
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1060-5. PubMed ID: 18483326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.